Add BrightSurf on Google Email

Image-guided treatment for deep venous thrombosis could improve patients' long-term outcomes

Researchers explore image-guided interventional radiology procedures as a central role in treating DVT. These techniques aim to eliminate blood clots completely, potentially improving patient outcomes and preventing long-term complications. A national clinical trial is underway to confirm the effectiveness of this approach.

SourceAmerican College of Radiology·JournalAmerican Journal of Roentgenology·DateSep 21, 2009

Circulating tumor cells a must watch

Researchers developed a simple biological imaging system to visualize live tumor cells in peripheral blood. The technology reflects the tumor burden, decreasing upon primary tumor removal, holding promise for clinical benefit.

SourceJCI Journals·JournalJournal of Clinical Investigation·DateSep 1, 2009

Bypassing bypass surgery

Researchers at Tel Aviv University have developed a protein-based injection that can regrow blood vessels in the human heart, eliminating the risk of cardiac attack and potentially replacing bypass surgeries. The therapy has shown no side effects or inflammation in animal models, paving the way for potential commercial availability.

SourceAmerican Friends of Tel Aviv University·JournalBiochemical Pharmacology·DateAug 13, 2009

New no-needle approach to prevent blood clots

Researchers have developed a new oral anti-clotting drug called Apixaban that is effective in preventing blood clots and reducing bleeding risk by half. The treatment was tested in a double-blind study of over 3,000 patients and proved to be a major step forward in preventing deadly blood clots after joint replacement surgery.

SourceUniversity of Oklahoma·JournalNew England Journal of Medicine·DateAug 11, 2009

JCI online early table of contents: July 1, 2009

Researchers have found that the circadian clock protein Period 1 regulates expression of the renal epithelial sodium channel in mice, leading to decreased sodium loss in urine. Additionally, a study on gene therapy revealed that TLR9-MyD88 pathway is critical for adaptive immune responses to AAV vectors. Another study on kidney repair ...

SourceJCI Journals·JournalJournal of Clinical Investigation·DateJul 1, 2009

Johns Hopkins scientists out a gene for gout

Researchers found the malfunctioning ABCG2 gene can lead to high urate levels, causing inflammation and pain. The gene is responsible for transporting urate out of the kidney and into urine, and its mutation may be linked to 10% of gout cases in Caucasians.

SourceJohns Hopkins Medicine·JournalProceedings of the National Academy of Sciences·DateJun 18, 2009

An easy way to find a needle in a haystack by removing the haystack

Researchers at Max Planck Institute for Chemical Ecology developed a new method, called MAILD, to quickly and reliably detect metabolites in biological samples. The technique uses classical mass spectrometry and enables the measurement of a large number of metabolites, opening doors for targeted and high-throughput metabolomics.

SourceMax Planck Institute for Chemical Ecology·JournalProceedings of the National Academy of Sciences·DateJun 18, 2009

Mosquito evolution spells trouble for Galapagos wildlife

Researchers discovered that the Galapagos giant tortoise and marine iguana are targeted by mosquitoes feeding on reptile blood, raising fears of devastating native wildlife diseases. The mosquito's adaptation to life in Galapagos could enable rapid spread of new diseases due to the islands' lack of immunity.

SourceUniversity of Leeds·JournalProceedings of the National Academy of Sciences·DateJun 1, 2009

Women with gestational diabetes during pregnancy have a substantial and persistently elevated risk of type 2 diabetes post birth

A recent study found that women who develop gestational diabetes during pregnancy are seven-and-a-half times more likely to develop type 2 diabetes post-birth. This increased risk remains for several years, emphasizing the need for continued monitoring and intervention. Early identification and treatment of related factors, such as lip...

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 21, 2009